All news (page 9)

25 September 2026

Enagás first Spanish company certified by AENOR under UNE-EN IEC 62443-2-1

Certification recognises cybersecurity management programme protecting the Yela underground gas storage facility in Guadalajara.
25 September 2026

Daiichi Sankyo and Merck withdraw US BLA for ifinatamab deruxtecan in ES‑SCLC

BLA for I‑DXd seeking accelerated approval in extensive‑stage SCLC withdrawn after FDA said Phase 2 data were insufficient; Phase 3 programmes continue.
25 September 2026

Lilly's Olumiant approved by FDA for severe alopecia areata in patients 12 and older

Oral baricitinib showed substantial scalp, eyebrow and eyelash regrowth in a Phase 3 pediatric trial; 4 mg and 2 mg doses outperformed placebo at Week 36.
25 September 2026

EIB-backed €80m loan for FNM Group hydrogen mobility

Financing supports hydrogen projects for rail and road to accelerate decarbonisation; backed by InvestEU and SACE guarantee; 15‑year tenor with 3‑year pre‑amortisation and 36‑month availability.
25 September 2026

BASF confirms exploratory takeover talks for Evonik

Acknowledges ongoing exploratory discussions; outcome remains uncertain. Says it will disclose material developments promptly under regulatory rules.
25 September 2026

Johnson & Johnson: CARVYKTI single infusion achieved five-year treatment-free remissions in 50% of early-line RRMM patients

Single CARVYKTI infusion produced treatment-free, progression-free remissions at five years in half of early-line relapsed/refractory multiple myeloma patients.
25 September 2026

Johnson & Johnson: TREMFYA first IL‑23 inhibitor to show spinal pain and stiffness benefit in axial PsA STAR study

Phase 4 STAR trial: guselkumab improved BASDAI at Week 24, reduced ASDAS‑CRP and MRI sacroiliac inflammation in biologic‑naïve axial PsA; safety profile consistent.
25 September 2026

MGC, Kokuka Sangyo & Hanshin Diesel complete Kokuryu Maru and undertake first methanol bunkering

New 498 GT chemical tanker to transport and bunker methanol; initial bunkering used biomethanol from Niigata plant; methanol fuel cuts CO2 by ~17.5% vs heavy fuel oil.
24 September 2026

CATL opens largest NING SERVICE centre in Europe in Oslo

8,000 m² centre for testing, repair, second‑life and recycling serving Norway and the Nordics; training hub with certified courses; part of a circularity push and wider European service network.
24 September 2026

Dutch minister seeks short-term amortisation decision to unlock national hydrogen network

Government will finalise a financing approach this year to give investors certainty and keep hydrogen transport tariffs affordable as market develops.
24 September 2026

Axens wins U.S. contract to design 100% tire pyrolysis oil hydroprocessing unit

U.S. project will upgrade 100% tire pyrolysis oil into low‑sulfur fuel (≤500 ppm); FEED underway and FID expected in 2027.
24 September 2026

Mercedes‑Benz & ProLogium agree joint testing of Gen4 solid‑state battery cells

Priority access to a new Gen4 inorganic solid‑state cell; Mercedes will run electrical, thermal and safety trials to assess suitability for future EV platforms.
24 September 2026

Eni awarded 100% Sapukala exploration licence in Kutei Basin

100% Sapukala deep-water block awarded; adjacent to major gas discoveries and covered by new seismic to speed evaluation.
24 September 2026

EIB and European Commission back VaxThera vaccine facility in Colombia

€15m first tranche of a €35m package to expand a Colombian plant to produce up to 250m doses annually, plus a €1.5m R&D grant for three vaccine candidates.
24 September 2026

Merck's remigromig meets primary endpoint in BRUNELLO Phase 2b/3 DME trial

Tri-specific Wnt-pathway agonist showed non-inferior BCVA gains vs ranibizumab at week 52; higher rates of PDR, vitreous hemorrhage and discontinuations observed.
24 September 2026

WuXi Biologics passes FDA GMP inspection at Wuxi Mashan

Passed a two-week unannounced FDA GMP inspection covering drug substance and drug product manufacturing, reinforcing U.S. commercial supply reliability.
24 September 2026

BioBTX and Rain Carbon to supply renewable aromatics

Convert plastic waste into about 10,000 t/y of renewable aromatic oil and downstream benzene, phthalic anhydride and aromatics for circular supply chains; first plant operational early 2028.
24 September 2026

Lilly's Onswik approved by FDA as once‑weekly basal insulin for adults with type 2 diabetes

FDA clears once‑weekly basal insulin that reduces injection frequency vs daily therapy; Phase 3 QWINT trials in >3,400 adults showed non‑inferior A1C vs glargine and degludec.
24 September 2026

European Commission T&Cs for €1bn industrial heat decarbonisation auction

€1bn Europe-wide auction for industrial process-heat decarbonisation; bidding opens early Dec 2026. Supports electrification, renewable heat and SMRs with a fixed premium per tCO2.
24 September 2026

Covestro and puren advance purenit® with ISCC PLUS certification and Desmodur® CQ MS binder

New production line and full ISCC PLUS certification enable mass‑balance bio‑circular binder use; lower‑carbon purenit® product slated for 2027 market launch.
24 September 2026

TOYO completes third fertilizer line for Indorama in Nigeria

Third line comprises 2,300 t/d ammonia and 4,000 t/d single-line urea (ACES21™); built adjacent to existing Port Harcourt complex; awarded 2023, completed June 2026.
23 September 2026

Johnson & Johnson: Model suggests Tec‑Dara may normalize long‑term mortality in early‑line RRMM

Modeling of MajesTEC‑3 trial data estimates a high cure fraction and nearly fourfold median OS benefit for teclistamab plus daratumumab FASPRO versus standard care in relapsed/refractory myeloma.
23 September 2026

Casale to supply 100 MTD modular green ammonia plant to Neptun in Glomfjord

SMART‑N technology under an EPF contract with modular off‑site fabrication, 10–100% operating range with staged hydrogen rollout and downstream conversion to nitric acid and fertilizers.
23 September 2026

Uniper and Arcadia eFuels agree 40,000 t/y eSAF offtake for Project Endor

40,000 t/yr eSAF commitment for 10+ years from Project Endor in Denmark; deliveries planned from early 2030s; fuel claims up to 98% lifecycle emissions reduction and EU compliance.
23 September 2026

Roche’s sefaxersen reduces proteinuria in phase III IMAgINATION trial

Interim analysis shows significant, clinically meaningful 24‑hour UPCR reduction at 37 weeks; blinded study continues to the eGFR endpoint at week 105.
23 September 2026

Prysmian and Aurubis sign largest long-term copper wire rod supply agreement

Long-term deal secures copper wire rod supply, increases access to recycled low‑carbon copper and bolsters Europe’s capacity for electrification, energy infrastructure and AI.
23 September 2026

BASF launches reduced‑PCF paper coating dispersions for cost‑effective Scope 3.1 reductions

Paper coating binders with ~20–45% lower cradle‑to‑gate PCF offered as drop‑in replacements, produced with low‑PCF raw materials and green utilities to support Purchased Goods & Services (Scope 3.1).
23 September 2026

TotalEnergies takes FID for Ima gas development in Nigeria

FID taken for Ima field offshore Bonny Island to feed NLNG Train 7; start-up 2028, plateau 350 MMscfd, single-platform 22 km tie-back, low-emissions design.
22 September 2026

Plug Power ships 1 MW GenEco electrolyzer to HWR Hydrogen in New Zealand

The 1 MW PEM electrolyzer will produce hydrogen for a refuelling station to supply dual‑fuel heavy trucks and help build South Island hydrogen infrastructure.
22 September 2026

Genentech's sefaxersen reduces proteinuria in Phase III IgAN interim analysis

Phase III interim data show significant proteinuria reduction at 37 weeks; drug targets liver-derived factor B via monthly subcutaneous dosing; blinded follow-up continues to week 105 eGFR.

← Previous Next →